Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
editorial
. 1998 May;42(5):1305. doi: 10.1128/aac.42.5.1305

Characterization of Mupirocin-Resistant Staphylococcus aureus from Different Geographic Areas

Mary A Ramsey 1,2,3,4, Suzanne F Bradley 1,2,3,4, Carol A Kauffman 1,2,3,4, Teresa M Morton 1,2,3,4, Jan E Patterson 1,2,3,4, David R Reagan 1,2,3,4
PMCID: PMC105817  PMID: 9593176

With the increasing use of mupirocin, resistance among staphylococci has emerged (1). High-level resistance (MICs, >500 μg/ml) is usually mediated by a plasmid-associated mupA gene. Low-level resistance (MICs, <100 μg/ml) is more common, can be selected in vitro with increasing concentrations of mupirocin, and, except for one report (7), has not been associated with mupA. We sought to define the characteristics and relatedness of Mupr strains from different geographic regions in the United States.

A total of 18 Staphylococcus aureus strains with high-level resistance (Hi-Mupr strains) and 19 S. aureus strains with low-level resistance (Lo-Mupr strains) were obtained from Ann Arbor, Mich.; Johnson City, Tenn.; and New Haven, Conn. (46, 8). Contour-clamped homogeneous electric field electrophoresis (CHEF) of genomic DNA was performed as described previously (7). Plasmid profile analysis was done following extraction of DNA by a rapid mini-prep procedure, treatment with HindIII, and separation of fragments by conventional agarose electrophoresis.

Southern analysis of chromosomal and plasmid DNA was performed according to standard procedures with a PCR-amplified product of an intragenic 1.65-kb NcoI fragment of mupA for the probe (7). Previously described oligonucleotide primers Mup1 and Mup2 were used for PCR amplifications (2). Filter mating experiments were carried out as described previously (3).

There were 11 Michigan strains (2 Hi-Mupr methicillin-resistant S. aureus [MRSA] and 9 Lo-Mupr [6 MRSA and 3 methicillin-susceptible S. aureus] strains), 14 Tennessee MRSA strains (6 Hi-Mupr and 8 Lo-Mupr strains), and 12 Connecticut strains (10 Hi-Mupr and 2 Lo-Mupr strains).

Eight different CHEF patterns were noted among the 37 strains. All 14 Tennessee strains were closely related and were similar to the 2 Hi-Mupr and to 5 of the 9 Lo-Mupr strains from Michigan; the 4 other Michigan strains showed three different patterns. Of the 12 Connecticut strains, 8 showed one predominant pattern and the other 4 showed three different patterns; all were unrelated to the Michigan and Tennessee strains.

All strains contained plasmids. Analysis of plasmid profiles showed differences between the Michigan and Tennessee strains that had appeared similar by CHEF typing; there were three different patterns among the 11 Michigan strains, and four entirely different patterns among the 14 Tennessee strains. The 12 strains from Connecticut showed five unique plasmid profiles.

All 18 Hi-Mupr strains transferred mupirocin resistance and contained mupA on plasmid DNA. The 2 Michigan strains carried mupA on a 9.1-kb fragment, the 6 Tennessee strains carried it on a 4.6- or a 5.5-kb fragment, and all 10 Connecticut strains carried it on a 4.6-kb fragment.

No Lo-Mupr strains transferred mupirocin resistance and, based on hybridization results, none had plasmid-associated mupA. In nine Michigan Lo-Mupr strains and two of eight Tennessee Lo-Mupr strains, the mupA probe hybridized to genomic DNA, indicating mupA is on the chromosome. No Connecticut Lo-Mupr strain showed hybridization to the mupA probe.

Both chromosomal and plasmid typing indicated that Connecticut strains were not related to Michigan and Tennessee strains. Although most of the strains from Michigan and Tennessee were closely related by CHEF typing, their plasmid profiles differed. Hi-Mupr S. aureus strains from the three geographic areas transferred resistance, but the plasmid location of the mupA gene varied.

Low-level mupirocin resistance was associated with chromosomal mupA in some but not all strains. Both high-level and low-level mupirocin resistance appeared to have arisen from multiple different clones within an individual institution and in different geographic areas of the United States.

REFERENCES

  • 1.Bradley S F, Ramsey M A, Morton T M, Kauffman C A. Mupirocin resistance: clinical and molecular epidemiology. Infect Control Hosp Epidemiol. 1995;16:354–358. doi: 10.1086/647125. [DOI] [PubMed] [Google Scholar]
  • 2.Hodgson J E, Curnock S P, Dyke K G H, Morris R, Sylvester D R, Gross M S. Molecular characterization of the gene encoding high-level mupirocin resistance in Staphylococcus aureus J2870. Antimicrob Agents Chemother. 1994;38:1205–1208. doi: 10.1128/aac.38.5.1205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Janssen D A, Zarins L T, Schaberg D R, Bradley S F, Terpenning M S, Kauffman C A. Detection and characterization of mupirocin resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 1993;37:2003–2006. doi: 10.1128/aac.37.9.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kauffman C A, Terpenning M S, He X, Zarins L T, Ramsey M A, Jorgenson K A, Bradley S F. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term care facility with the use of mupirocin ointment. Am J Med. 1993;94:371–378. doi: 10.1016/0002-9343(93)90147-h. [DOI] [PubMed] [Google Scholar]
  • 5.Layton M C, Patterson J E. Mupirocin resistance among consecutive isolates of oxacillin-resistant and borderline oxacillin-resistant Staphylococcus aureus at a university hospital. Antimicrob Agents Chemother. 1994;38:1664–1667. doi: 10.1128/aac.38.7.1664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Layton M C, Perez M, Heald P, Patterson J E. An outbreak of mupirocin-resistant Staphylococcus aureus on a dermatology ward associated with an environmental reservoir. Infect Control Hosp Epidemiol. 1993;14:369–375. doi: 10.1086/646764. [DOI] [PubMed] [Google Scholar]
  • 7.Ramsey M A, Bradley S F, Kauffman C A, Morton T M. Identification of chromosomal location of mupA gene encoding low-level mupirocin resistance in staphylococcal isolates. Antimicrob Agents Chemother. 1996;40:2820–2823. doi: 10.1128/aac.40.12.2820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Reagan D R, Dula R T, Palmer B H, Gutierrez C N, Franzus B F, Sarubbi F A. Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C: American Society for Microbiology; 1991. Control of MRSA in a VAMC with limited resources, abstr. 31; p. 104. [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES